Boosting Resources for Tracheostomy Care at Home (BREATHE)

February 21, 2024 updated by: Karen Sepucha, Massachusetts General Hospital

Boosting Resources and Caregiver Empowerment for Trach Care at Home: A Pragmatic Randomized Trial

The goal of this trial is to advance our understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main questions it aims to answer are:

  • How can we support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can we leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will be randomly assigned to receive Trach Me Home (gold standard discharge program) or Trach Me Home with additional components. Caregiver participants will complete three surveys over the course of 6 months. Researchers will see if caregivers in the Trach Me Home with additional components report lower caregiver burden at 4 weeks post discharge (primary outcome) and fewer hospital readmissions at 6 months than those in Trach Me Home arm.

Study Overview

Status

Not yet recruiting

Detailed Description

The study is focused on a rare and medically complex population of children with tracheostomies. The study is a Type I hybrid effectiveness-implementation study using a pragmatic randomized trial at six participating sites. The goal of this trial is to advance our understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main question[s] it aims to answer are:

  • How can we support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can we leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will randomly assigned to the Comparator arm (gold standard discharge program) or to the Intervention arm (gold standard program with other components). Caregiver participants will complete three surveys over the course of 6 months. We will test two main hypotheses: the Intervention arm will have (1) significantly lower caregiver burden at 4 weeks post discharge (primary outcome) and (2) significantly lower readmissions or emergency room visits at 6 months post discharge than the Comparator arm.

We will also survey pediatricians of participating patients at 6 months post discharge and examine whether intervention arm pediatricians have higher satisfaction with discharge communication than those in comparator arm.

Study Type

Interventional

Enrollment (Estimated)

480

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • La Jolla, California, United States, 92093
        • University of San Diego Rady Children's Hospital
        • Contact:
        • Principal Investigator:
          • Matthew Brigger, MD
    • Maryland
      • Silver Spring, Maryland, United States, 20910
        • Children's National Medical Center, Children's Research Institute
        • Contact:
        • Principal Investigator:
          • Habib Zalzal, MD
    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital
        • Contact:
        • Contact:
          • Christopher Hartnick, MD
    • Minnesota
      • Minneapolis, Minnesota, United States, 55404
    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Cincinnati Children's Hospital Medical Center
        • Principal Investigator:
          • Matthew Smith, MD
        • Contact:
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19146
        • Children's Hospital of Philadelphia
        • Contact:
        • Principal Investigator:
          • Luv Javia, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Lead or primary adult caregiver (18 or older) of infants or children (0-17 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator

Exclusion Criteria:

  • Patients transferred to other hospital or facility (and/or not discharged to home during study period)
  • Primary caregiver unable to read or write in English, Spanish, Mandarin, or Arabic
  • Not planning to reside in the U.S. for at least 12 months after discharge

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active Comparator Caregivers
TrachMeHome program delivered in the hospital including education, skills training and case management for caregivers
The Trach Me Home discharge program includes caregiver education, skills training and case management.
Experimental: Intervention Caregivers
Trach Me Home and Trach@Home with additional education, outpatient care team communication and social support for caregivers.
The Trach Me Home discharge program includes caregiver education, skills training and case management.
The Trach@Home program includes education, social support, and outreach to outpatient care team.
Active Comparator: Active Comparator Physicians
Primary care physicians' of the enrolled participant's child receiving discharge communication
The Trach Me Home discharge program includes caregiver education, skills training and case management.
Experimental: Intervention Physicians
Primary care physicians' of the enrolled participant's child receiving outpatient care team communication prior to discharge
The Trach Me Home discharge program includes caregiver education, skills training and case management.
The Trach@Home program includes education, social support, and outreach to outpatient care team.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver Burden
Time Frame: 4 weeks post-discharge
Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, higher scores indicate higher burden
4 weeks post-discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medical Complications Associated with Tracheostomy
Time Frame: 6 months post-discharge
Adapted version of Medical Complications Associated with Tracheostomy scale that includes 4 caregiver reported items assessing urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Higher scores are worse.
6 months post-discharge
6-month Readmission Rate
Time Frame: 6 months post-discharge
Percentage with one or more electronic health record documented emergency room visits or hospital readmissions
6 months post-discharge
Frequency of pediatrician communication
Time Frame: 6 months post-discharge
Percentage of clinicians that reported communication with inpatient team prior to and/or shortly after discharge
6 months post-discharge
Primary care pediatrician satisfaction
Time Frame: 6 months post-discharge
Clinician reported satisfaction with discharge communication score, higher scores indicate higher satisfaction
6 months post-discharge

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medical Complications Associated with Tracheostomy
Time Frame: 4 weeks post-discharge
Adapted version of Medical Complications Associated with Tracheostomy scale that includes 4 caregiver reported items assessing urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Higher scores are worse.
4 weeks post-discharge
Caregiver Burden
Time Frame: 6 months post-discharge
Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, higher scores indicate higher burden.
6 months post-discharge
Number of readmissions
Time Frame: 6 months post discharge
The total number of electronic health record documented emergency room visits and hospital admissions will be collected, with higher numbers being worse (indicating more readmissions).
6 months post discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen Sepucha, PhD, Massachusetts General Hospital
  • Principal Investigator: Christopher Hartnick, MD, Massachusetts Eye and Ear Infirmary / Massachusetts General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

February 21, 2024

First Submitted That Met QC Criteria

February 21, 2024

First Posted (Actual)

February 28, 2024

Study Record Updates

Last Update Posted (Actual)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 21, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023P001695
  • IHS-2022C1-26100 (Other Grant/Funding Number: Patient Centered Outcomes Research Institute (PCORI))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

To promote research replicability, transparency and future use of the data, de-identified data sets will be created and will be available, by request, to outside researchers.

The Data Package (comprised of the de-identified Analyzable Data Set, Full Protocol, metadata, data dictionary, full statistical analysis plan, and analytic code from the project) will be deposited in the Patient-Centered Outcomes Research Institute's Data Repository at the ICPSR. Participant information sheets for the study will indicate that de-identified information will be deposited in an open access service to promote use of the data by other researchers. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set. No data will be provided from qualitative transcripts as this may lead to identifying information about participants. However, codes abstracted from qualitative transcripts may be made available.

IPD Sharing Time Frame

After study results have been published, about 1 year after the end of the funded grant period, the study materials and de-identified data will be placed on an open access service such as ICPSR where they will be available indefinitely.

IPD Sharing Access Criteria

Researchers may access the data through the PCORI-designated repository (ICPSR's website) once it is made available.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tracheostomy

Clinical Trials on Trach Me Home

3
Subscribe